Loading stock data…
$7.04+0.03 (+0.43%)
Profound Medical Corp.
Profound Medical Corp. in the Healthcare sector is trading at $7.04 with a market capitalization of $218M. Wall Street consensus targets $11.14 (5 analysts), implying a +58.2% move over the next 12 months. The stock is currently 21% below its 52-week high of $8.95, remaining 3.5% above its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality, Altman Z in the safe zone. The Whystock Score of 100/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $2.48M↓ | $5.34M↓ | $5.98M↑ | $5.29M↑ | $2.21M |
| Gross Profit | $1.95M↓ | $3.83M↓ | $3.99M↑ | $3.93M↑ | $1.62M |
| Operating Income | -$11.07M↓ | -$8.02M↓ | -$7.37M↑ | -$8.91M↑ | -$13.81M |
| Net Income | -$9.54M↓ | -$7.05M↑ | -$8.18M↓ | -$7.98M↑ | -$15.70M |
Profound Medical Corp. operates as a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapeutic systems for the image guided ablation of diseased tissue. The company's lead product TULSA-PRO sy...